INNOSPEC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.4 USD | +0.82% |
|
-1.03% | -0.67% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,534 | 2,230 | 2,227 | 2,547 | 3,064 | 3,052 | - |
| Enterprise Value (EV) 1 | 2,517 | 2,125 | 2,227 | 2,400 | 3,064 | 3,052 | 3,052 |
| P/E ratio | 22.8 x | 78.2 x | 24.1 x | 19.3 x | 22.2 x | 19.8 x | 17.3 x |
| Yield | 0.99% | 1.15% | 1.28% | - | 1.14% | 1.27% | 1.29% |
| Capitalization / Revenue | 1.67 x | 1.87 x | 1.5 x | 1.3 x | 1.57 x | 1.54 x | 1.44 x |
| EV / Revenue | 1.67 x | 1.87 x | 1.5 x | 1.3 x | 1.57 x | 1.54 x | 1.44 x |
| EV / EBITDA | 12.6 x | 20.5 x | 12.5 x | 11.3 x | 14.6 x | 12.7 x | 11.3 x |
| EV / FCF | 19.2 x | 19.2 x | 41.2 x | 60.5 x | 21.1 x | 19.2 x | 21.4 x |
| FCF Yield | 5.2% | 5.21% | 2.43% | 1.65% | 4.74% | 5.21% | 4.68% |
| Price to Book | 2.76 x | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 24,496 | 24,580 | 24,647 | 24,765 | 24,866 | 24,933 | - |
| Reference price 2 | 103.4 | 90.73 | 90.34 | 102.9 | 123.2 | 122.4 | 122.4 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,513 | 1,193 | 1,483 | 1,964 | 1,949 | 1,984 | 2,114 |
| EBITDA 1 | 201.8 | 108.9 | 178.2 | 225.4 | 210.6 | 240 | 269.8 |
| EBIT 1 | 149.9 | 33.7 | 132.1 | 187.3 | 161.6 | 193.5 | 231 |
| Operating Margin | 9.91% | 2.82% | 8.91% | 9.54% | 8.29% | 9.75% | 10.92% |
| Earnings before Tax (EBT) 1 | 150.4 | 39.7 | 134.4 | 184.6 | 174.4 | 210.2 | 245.8 |
| Net income 1 | 112.2 | 28.7 | 93.1 | 133 | 139.1 | 157.6 | 184.4 |
| Net margin | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 7.94% | 8.72% |
| EPS 2 | 4.540 | 1.160 | 3.750 | 5.320 | 5.560 | 6.190 | 7.070 |
| Free Cash Flow 1 | 131.7 | 116.2 | 54.1 | 42.1 | 145.2 | 159 | 143 |
| FCF margin | 8.7% | 9.74% | 3.65% | 2.14% | 7.45% | 8.01% | 6.76% |
| FCF Conversion (EBITDA) | 65.26% | 106.7% | 30.36% | 18.68% | 68.95% | 66.26% | 52.98% |
| FCF Conversion (Net income) | 117.38% | 404.88% | 58.11% | 31.65% | 104.39% | 100.89% | 77.54% |
| Dividend per Share 2 | 1.020 | 1.040 | 1.160 | - | 1.410 | 1.560 | 1.580 |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 413.2 | 472.4 | 467.6 | 513 | 510.7 | 509.6 | 480.4 | 464.1 | 494.7 | 500.2 | 468.7 | 506.5 | 509.1 | 527.3 | 508.1 |
| EBITDA 1 | 44.8 | 59 | 52.9 | 59.2 | 54.3 | 53.9 | 46.2 | 56.5 | 54 | 64 | 53.27 | 61.03 | 65.67 | 70.65 | 65.45 |
| EBIT 1 | 35.5 | 44.3 | 46.3 | 50.1 | 46.6 | 41 | 34.2 | 41.9 | 44.5 | 50.5 | 39.8 | 50.45 | 55.3 | 56.5 | 52.8 |
| Operating Margin | 8.59% | 9.38% | 9.9% | 9.77% | 9.12% | 8.05% | 7.12% | 9.03% | 9% | 10.1% | 8.49% | 9.96% | 10.86% | 10.71% | 10.39% |
| Earnings before Tax (EBT) 1 | 32.7 | 48.2 | 42.3 | 48.9 | 45.2 | 45 | 36.6 | 47.5 | 45.3 | 55.3 | 42.8 | 53.5 | 58.65 | 60.2 | 56.4 |
| Net income 1 | 23.9 | 36.5 | 32.3 | 38.7 | 25.5 | 33.2 | 28.9 | 39.2 | 37.8 | 41.4 | 32.15 | 40.1 | 43.95 | 45.2 | 42.3 |
| Net margin | 5.78% | 7.73% | 6.91% | 7.54% | 4.99% | 6.51% | 6.02% | 8.45% | 7.64% | 8.28% | 6.86% | 7.92% | 8.63% | 8.57% | 8.33% |
| EPS 2 | 0.9600 | 1.460 | 1.290 | 1.550 | 1.020 | 1.330 | 1.160 | 1.570 | 1.510 | 1.650 | 1.270 | 1.550 | 1.710 | 1.800 | 1.690 |
| Dividend per Share 2 | 0.5900 | - | 0.6300 | - | - | - | 0.6900 | - | 0.7200 | - | 0.7600 | - | 0.8000 | - | - |
| Announcement Date | 2/15/22 | 5/3/22 | 8/2/22 | 11/8/22 | 2/21/23 | 5/3/23 | 8/8/23 | 11/7/23 | 2/13/24 | 5/9/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | 17.1 | 105 | - | 147 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 132 | 116 | 54.1 | 42.1 | 145 | 159 | 143 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | 37.50 | - | - | - | - | - | - |
| Cash Flow per Share | 6.540 | - | - | - | - | - | - |
| Capex 1 | 29.9 | 29.7 | 39.1 | 39.6 | 62.1 | 56.4 | 60 |
| Capex / Sales | 1.98% | 2.49% | 2.64% | 2.02% | 3.19% | 2.84% | 2.84% |
| Announcement Date | 2/18/20 | 2/16/21 | 2/15/22 | 2/21/23 | 2/13/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
122.4
USD
Average target price
137.5
USD
Spread / Average Target
+12.32%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.67% | 3.05B | |
| +18.81% | 67.29B | |
| +23.71% | 43.72B | |
| +37.17% | 28.07B | |
| +8.59% | 19.24B | |
| +15.16% | 17.22B | |
| -27.02% | 14.64B | |
| -14.48% | 14.51B | |
| -32.66% | 11.58B | |
| -32.82% | 11.41B |
- Stock Market
- Equities
- IOSP Stock
- Financials Innospec Inc.
